Skip to main content
About Alexion

The Alexion Charitable Foundation

Bringing promise, hope, and belonging to people affected by rare
disease.

Addressing Health Disparities in the Rare Disease Community

The Alexion Charitable Foundation (ACF) is designed to have the most positive impact possible on the communities we serve. Our mission is to address the health disparities within and among the rare disease community.

We invest in projects to ensure that all underserved communities have equitable pathways to the care, services and resources they need to live healthier lives.

 Our Funding Priorities   

Pioneers in Science

Science-Driven Solutions

Close gaps in early symptom recognition and increase access to clinical, genetic and diagnostic testing.

Technology & Innovation

Enhance diagnostic accuracy and speed through technology advances and breakthroughs.

Patient Focused Innovators

Patient Supports

Help rare disease patients and caregivers access interventions and care throughout the diagnosis journey.

Champtioning Health Equity

Research & Policy

Support policy generation efforts and lived-experience research focused on diagnostic pathways and systems improvements.

Making an Impact

The ACF is proud of its community partnerships around the world and the impact it has made through its current and past grant making programs. Focused on supporting the rare disease community.

2020

the year ACF was established, bringing the global rare disease community together to help more people.

1M+

people reached since 2020 with grants supporting improved healthcare services and resources.

71

charitable partners in 15 countries around the globe.

130

grants awarded since 2020 to help make a significant impact on the lives of people affected by rare disease.

For more information on ACF’s historical work and partnerships, see the annual report.

Medical Education and Patient Advocacy Grants

Learn more about funding opportunities for independent medical education and advocacy support services around the globe.

Veeva ID: GL/ALL/0052